However, in both AD mouse models and human patients, there is an atrophy of astroglia (both of cell volume and of processes), accompanied by reactive astrocytes characterised by increased volume and an increase in glial fibrillary acidic protein (GFAP) expression [296, 297]. The gene discussed is GFAP; the disease is Alzheimer disease.